These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33301428)

  • 21. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
    Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
    Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is cell-based therapy more efficacious for people with amyotrophic lateral sclerosis/motor neuron disease than placebo or no treatment? - A Cochrane review summary with commentary.
    Ceravolo MG
    NeuroRehabilitation; 2020; 46(4):613-615. PubMed ID: 32538885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results.
    Gotkine M; Caraco Y; Lerner Y; Blotnick S; Wanounou M; Slutsky SG; Chebath J; Kuperstein G; Estrin E; Ben-Hur T; Hasson A; Molakandov K; Sonnenfeld T; Stark Y; Revel A; Revel M; Izrael M
    J Transl Med; 2023 Feb; 21(1):122. PubMed ID: 36788520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy - a perspective on cell biological mechanisms.
    Tang BL
    Rev Neurosci; 2017 Oct; 28(7):725-738. PubMed ID: 28599400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular transplants in amyotrophic lateral sclerosis patients: an observational study.
    Gamez J; Carmona F; Raguer N; Ferrer-Sancho J; Martín-Henao GA; Martí-Beltrán S; Badia M; Gratacós M; Rodriguez-Gónzalez E; Seoane JL; Pallero-Castillo M; Burgos R; Puiggros C; Pasarin A; Bori-Fortuny I
    Cytotherapy; 2010 Sep; 12(5):669-77. PubMed ID: 20586670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients.
    Ferrero I; Mazzini L; Rustichelli D; Gunetti M; Mareschi K; Testa L; Nasuelli N; Oggioni GD; Fagioli F
    Cell Transplant; 2008; 17(3):255-66. PubMed ID: 18522229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metalloproteinase alterations in the bone marrow of ALS patients.
    Bossolasco P; Cova L; Calzarossa C; Servida F; Mencacci NE; Onida F; Polli E; Lambertenghi Deliliers G; Silani V
    J Mol Med (Berl); 2010 Jun; 88(6):553-64. PubMed ID: 20091292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Pius-Sadowska E; Litwińska Z; Kotowski M; Meller A; Rotter I; Peregud-Pogorzelski J; Nowacki P
    Int J Med Sci; 2020; 17(13):1927-1935. PubMed ID: 32788871
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors.
    Javorkova E; Matejckova N; Zajicova A; Hermankova B; Hajkova M; Bohacova P; Kossl J; Krulova M; Holan V
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):215-225. PubMed ID: 30242613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial.
    Mazzini L; Ferrero I; Luparello V; Rustichelli D; Gunetti M; Mareschi K; Testa L; Stecco A; Tarletti R; Miglioretti M; Fava E; Nasuelli N; Cisari C; Massara M; Vercelli R; Oggioni GD; Carriero A; Cantello R; Monaco F; Fagioli F
    Exp Neurol; 2010 May; 223(1):229-37. PubMed ID: 19682989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis.
    Magota H; Sasaki M; Kataoka-Sasaki Y; Oka S; Ukai R; Kiyose R; Onodera R; Kocsis JD; Honmou O
    Mol Brain; 2021 May; 14(1):76. PubMed ID: 33962678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
    Baek W; Kim YS; Koh SH; Lim SW; Kim HY; Yi HJ; Kim H
    J Neurosurg Sci; 2012 Sep; 56(3):261-3. PubMed ID: 22854595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-PIX is critical for transplanted mesenchymal stromal cell migration.
    Koh SH; Huh YM; Noh MY; Kim HY; Kim KS; Lee ES; Ko HJ; Cho GW; Yoo AR; Song HT; Hwang S; Lee K; Haam S; Frank JA; Suh JS; Kim SH
    Stem Cells Dev; 2012 Jul; 21(11):1989-99. PubMed ID: 22087847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus.
    Rushkevich YN; Kosmacheva SM; Zabrodets GV; Ignatenko SI; Goncharova NV; Severin IN; Likhachev SA; Potapnev MP
    Bull Exp Biol Med; 2015 Aug; 159(4):576-81. PubMed ID: 26395626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial.
    Nabavi SM; Arab L; Jarooghi N; Bolurieh T; Abbasi F; Mardpour S; Azimyian V; Moeininia F; Maroufizadeh S; Sanjari L; Hosseini SE; Aghdami N
    Cell J; 2019 Jan; 20(4):592-598. PubMed ID: 30124008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
    Cudkowicz ME; Lindborg SR; Goyal NA; Miller RG; Burford MJ; Berry JD; Nicholson KA; Mozaffar T; Katz JS; Jenkins LJ; Baloh RH; Lewis RA; Staff NP; Owegi MA; Berry DA; Gothelf Y; Levy YS; Aricha R; Kern RZ; Windebank AJ; Brown RH
    Muscle Nerve; 2022 Mar; 65(3):291-302. PubMed ID: 34890069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis.
    Lewis CM; Suzuki M
    Stem Cell Res Ther; 2014; 5(2):32. PubMed ID: 25157751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol.
    Yun YC; Jeong SG; Kim SH; Cho GW
    J Tissue Eng Regen Med; 2019 Jan; 13(1):110-115. PubMed ID: 30479062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical studies of mesenchymal stem cells transplantation in amyotrophic lateral sclerosis: a systemic review and metaanalysis.
    Zhou Q; Yuan M; Qiu W; Cao W; Xu R
    Neurol Sci; 2021 Sep; 42(9):3637-3646. PubMed ID: 33433755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of host and graft after cell sheet transplantation: Basic study for the application of amyotrophic lateral sclerosis.
    Nakanishi M; Watanabe Y; Honda N; Une M; Kazuki K; Kazuki Y; Terashima T; Katagi M; Nakashima K; Hanajima R
    Brain Res; 2019 Dec; 1724():146444. PubMed ID: 31518575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.